Last updated 21 days ago

A Study Evaluating the Efficacy and Safety of Giredestrant Plus Everolimus Compared With the Physician's Choice of Endocrine Therapy Plus Everolimus in Participants With Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer (evERA Breast Cancer)

320 patients around the world

Available in United States, Argentina

Genentech, Inc.

15Research sites

320Patients around the world

This study is for people with

Breast Cancer

Requirements for the patient

From 18 Years

All Gender

Medical requirements

Sites

Centro Polivalente de Asistencia e Investigación Clínica - CER San Juan

Recruiting

Laprida 532 Este, San Juan

Centro Médico Privado CEMAIC - Córdoba

Recruiting

Monseñor Pablo Cabrera 2941, Córdobawww.cemaic.com.ar

Centro de Investigaciones Clínicas - Clínica Viedma - Río Negro

Recruiting

25 de mayo 174, Viedma, Río Negrowww.imoviedma.com.ar

Hospital Provincial del Centenario - Rosario, Santa Fe

Recruiting

Urquiza 3101, Rosario, Santa Fe

Organización Médica de Investigación (OMI)

Recruiting

Uruguay 725 PB , Buenos Aires, CP: 1015

Centro Oncológico de Integración Regional C.O.I.R.

Recruiting

Monte Caseros 1020, Mendoza

Instituto de Oncología Ángel H. Roffo - CABA, Buenos Aires

Recruiting

Av. San Martín 5481, CABA, Buenos Aires

Instituto de Oncología de Rosario - IOR

Recruiting

Córdoba 2457, Rosario, Santa Fe

Consultorios Médicos Dr. Doreski

Recruiting

Av. Cabildo, Cdad. Autónoma de Buenos Aires, Argentina

Fundación CENIT para la Investigación en Neurociencias

Recruiting

Juncal 2222, C1125 CABA, Argentina

Sanatorio Parque - Rosario

Recruiting

Boulevard Oroño 860, Rosario, Santa Fe

Hospital Privado de la Comunidad

Recruiting

Córdoba 4545, Mar del Plata, Buenos Aires

Instituto Médico de la Fundación Estudios Clínicos - Rosario

Recruiting

Italia 428, Rosario - Santa Fe

Sanatorio Allende (Nueva Córdoba)

Recruiting

Hipolito Yrigoyen 384, Córdoba

Centro de Investigación Pergamino SA

Recruiting

Av. de Mayo 1115, Pergamino, Buenos Aires

StudyevERA

SponsorGenentech, Inc.

Conditions

Breast Cancer

Requirements

From 18 YearsAll Gender

Unique study IDclinicaltrials.gov

NCT05306340